Is 1:1 Always Most Powerful? Why Unequal Allocation Merits Broader Consideration
Lukas Pin *, Stef Baas, David S. Robertson, Sofía S. Villar · 2025
Read Is 1:1 Always Most Powerful? Why Unequal Allocation Merits Broader Consideration by Lukas Pin *, Stef Baas, David S. Robertson, Sofía S. Villar (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2507-13036.txt.
Introduction
Lukas Pin, Stef Baas, David Robertson, and Sofía Villar argue that equal arms in a trial are not always the most powerful design. Their paper from twenty twenty-five revisits a bedrock belief of randomized trials. Equal splits win only when outcome spread matches across arms. That match is often false, and rarely checked. Unequal splits can keep or gain power while more patients land on the better arm.
Two cases ground the claim: a small melanoma trial with a yes-no outcome, and a large pain trial using virtual reality. Simulations weigh equal, fixed unequal, and adaptive splits aimed at the Neyman target. Unequal plans put more patients on the winning arm with no power loss. Small power gains showed for both outcome types. The team urges designers to set ratios with care.
Catalog record
| CREATOR | Lukas Pin *, Stef Baas, David S. Robertson, Sofía S. Villar |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2507-13036
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Is 1:1 Always Most Powerful? Why Unequal Allocation Merits Broader Consideration Lukas Pin *, Stef Baas, David S. Robertson, Sofía S. Villar Abstract The principle of allocating an equal number of patients to each arm in a randomized controlled trial is widely accepted as the standard strategy for maximising the trial’s statistical power. However, this long-held belief only holds true if the treatment groups have equal outcome variances, a condition that is often not met in practice. This paper questions the prevalent practice of exclusively defaulting to equal randomisation (ER) and posits that a departure from a 1:1 ratio can be both valid and advantageous. We demonstrate this principle through two simulated case studies, one with a binary endpoint and one with a continuous endpoint, comparing the performance of ER against preplanned Fixed Unequal Randomisation and Response-Adaptive Randomisation targeting Neyman allocation. Our results show that unequal ratios can increase statistical power while simultaneously allocating a substantially larger proportion of patients to the superior treatment arm compared to ER. We conclude that, when unequal variances are suspected, a strategic decision regarding the allocation ratio –- rather than a default 1:1 –- constitutes the superior design choice. Keywords Wald test, Patient-benefit, Fixed Randomisation, Unequal Randomisation Ratios, Neyman Allocation, Expected Patient Outcomes 1 Introduction Many trialists and statisticians strongly adhere to the principle that allocating an equal number of patients to each arm in a 1:1 ratio results in the most efficient design, maximising the study’s statistical power. This belief is frequently found in review articles ( Dumville et al. 2006 ; Dibao-Dina et al. 2014 ; Berger et al. 2021 ; Freidlin and Korn 2024 ) , for instance: “balanced group sizes will maximise a study’s statistical power" ( Dumville et al. 2006 ) . The principle is further reinforced by influential textbooks ( Pocock 2013 ; Friedman et al. 2015 ) . For example, Chapter 9 of Pocock 2013 details standard power calculations where formulas implicitly assume a 1:1 patient allocation, yielding n_{C}=n_{T} patients per treatment arm (control ( C ) and treatment ( T )). Building the equal allocation ratio into standard sample size formulae calculations, whether intentional or not, elevates the 1:1 ratio as the default. The rationale for an equal allocation ratio default is multifaceted ( Avins 1998 ) , reflecting not just statistical considerations but also ethical, financial, and practical ones, including patient recruitment. However, conclusions may be flawed if they rest on the assumption that an equal ratio inherently maximizes power ( Torgerson and Campbell 1997 ; Wu et al. 2014 ; Nay et al. 2024 ) . These arguments are often conflated with the ethical and practical justifications being reinforced by the assumption that equal allocation is always the most statistically powerful design: “Trials using unequal allocation will therefore either have less statistical power or will be more expensive and entail exposing more patients than necessary to a novel intervention and research procedures." ( Hey and Kimmelman 2014 ) . This long-held assumption that equal allocation maximises power is conditional. Its mathematical validity rests on the crucial prerequisite that the outcome variances within the compared groups are equal. Yet, this assumption of homoscedasticity is often questionable in practice and may often be violated in many settings ( Ruxton 2006 ) . When this condition of equal variances is not met, the optimality of equal allocation is no longer guaranteed. This means that by moving away from a 1:1 ratio, we may achieve superior performance, for instance, through fixed unequal allocation (by sampling more from the more variable arm) or through Response-Adaptive Randomisation (RAR), where allocation probabilities are dynamically adjusted as data accrues and variance estimates improve. The objective of this paper is to challenge the conventional default application of equal allocation and establish a fundamental point: that equal allocation is not a universal optimum. We argue that a well-reasoned allocation ratio, informed by beliefs about outcome variances (even if it deviates from equal allocation), is a superior option to defaulting to 1:1 without careful consideration of outcome group variability. 2 The statistical rationale for increasing power The allocation ratio that maximises statistical power for a given test statistic depends on: 1. the type of endpoint (binary, discrete, continuous), 2. the measure of interest (e.g., mean difference, odds ratio), 3. and, most critically, the variance of the outcome within each treatment arm. We illustrate how the above elements interplay when aiming to maximise power using the simple Wald test for comparing two group means. For this test, it has been shown that comparing groups under heteroscedasticity, sampling with an unequal ratio can increase statistical power ( Tschuprow 1923 ; Neyman 1934 ; Robbins 1952 ; Rosenberger et al. 2001 ) . By treating the question as a formal optimization problem, one can derive the optimal allocation strategy for the Wald test. This principle, known as Neyman allocation , dictates that to maximize power for a fixed total sample size, the allocation ratio between the treatment and control arms should be proportional to the standard deviations of the outcomes in each group: \frac{n_{T}}{n_{C}}=\frac{\sigma_{T}}{\sigma_{C}} (1) Formula ( 1 ) demonstrates, that {n_{T}}={n_{C}} is only optimal when variances are equal ( \sigma_{T}=\sigma_{C} ). Otherwise, maximising statistical power necessitates allocating more patients to the arm with higher expected variance. In the case of binary endpoints, the variance \sigma_{i}^{2}=p_{i}(1-p_{i}) within each arm ( i=C,T ) is determined by its success rate, p_{i} . Applying the principle of Neyman allocation reveals a critical nuance: ER is only optimal under the null hypothesis ( p_{C}=p_{T} ) or where the success rates are symmetric around 0.5 (i.e., p_{C}=1-p_{T} ), see Figure 1 . This figure also elucidates the possibility of a conflicting situation where maximising statistical power requires the allocation ratio to shift in a direction that favors the currently worse-performing treatment arm. (a) (b) (c) (d) Figure 1: The horizontal axis shows the varying value of p_{1} while p_{0} takes a fixed value in each sub figure. For each combination of p_{1} and p_{0} the vertical axis shows the value of the theoretical Neyman allocation ( \rho_{N_{1}} ) and Equal Randomisation ( \rho_{\text{ER}} ). Notice that as Neyman allocation is symmetric around 0.5 each sub figure represent two p_{0} values. This highlights a broader principle: when maximising statistical power, the optimal allocation depends heavily on the context. For instance, with time-to-event data that is exponentially distributed, Neyman allocation always assigns more patients to the superior arm ( Baldi Antognini et al. 2020 ) . Furthermore, the choice of effect measure and the statistical test itself alter the optimal ratio ( Pin et al. 2024 ) . More generally, power is optimized by the allocation that maximizes the test statistic’s non-centrality parameter ( Hu and Rosenberger 2003 ) , which for the Wald test, leads to Neyman allocation ( Rosenberger et al. 2001 ) . We conclude this section with the theoretical insight that equal allocation can only be expected to be optimal in terms of statistically power only under homoscedasticity; its practical implications will be investigated in the next section. 3 Examples to quantify power improvements Having established that an equal ratio is not always optimal, we now illustrate just how inefficient it